Registrati gratuitamente per ottenere quotazioni in tempo reale, grafici interattivi, flusso di opzioni in tempo reale e altro ancora.
| Data | Nome del titolare | Azioni transazionate | Intervallo di valore ($) | Tipo di transazione | Intervallo di prezzo ($) | Azioni a fine dichiarazione | % di variazione |
|---|---|---|---|---|---|---|---|
| 2026-01-12 | Mr. Mark HollywoodExec. VP & COO | 11,55k | 0,00 | Derivative Exercise and Retained Stock | - | 132,91k | 9,51% |
| 2026-01-12 | Mr. Mark HollywoodExec. VP & COO | -6,12k | 138,76k | Derivative Exercise and Sale | 22,67 | 132,91k | - |
| 2026-01-12 | Dr. Jeffrey T. L. SmithInsider | 8,36k | 0,00 | Derivative Exercise and Retained Stock | - | 26,71k | 45,53% |
| 2026-01-12 | Dr. Jeffrey T. L. SmithInsider | -9,31k | 211,09k | Derivative Exercise and Sale | 22,67 | 26,71k | - |
| 2026-01-12 | Dr. Paul A. MooreChief Scientific Officer | 8,11k | 0,00 | Derivative Exercise and Retained Stock | - | 48,50k | 20,07% |
| 2026-01-12 | Dr. Paul A. MooreChief Scientific Officer | -9,56k | 216,76k | Derivative Exercise and Sale | 22,67 | 48,50k | - |
| 2026-01-12 | Mr. Kenneth H. GalbraithChairman of the Board, CEO & President | 33,58k | 0,00 | Derivative Exercise and Retained Stock | - | 226,84k | 17,37% |
| 2026-01-12 | Mr. Kenneth H. GalbraithChairman of the Board, CEO & President | -30,42k | 689,82k | Derivative Exercise and Sale | 22,67 | 226,84k | - |
| 2026-01-05 | Dr. Jeffrey T. L. SmithInsider | 9,46k | 0,00 | Derivative Exercise and Retained Stock | - | 18,35k | 106,43% |
| 2026-01-05 | Dr. Jeffrey T. L. SmithInsider | -10,54k | 264,47k | Derivative Exercise and Sale | 25,10 | 18,35k | - |
| 2026-01-05 | Mr. Kenneth H. GalbraithChairman of the Board, CEO & President | 59,99k | 0,00 | Derivative Exercise and Retained Stock | - | 193,27k | 45,01% |
| 2026-01-05 | Mr. Kenneth H. GalbraithChairman of the Board, CEO & President | -54,34k | 1,36M | Derivative Exercise and Sale | 25,10 | 193,27k | - |
| 2026-01-05 | Dr. Paul A. MooreChief Scientific Officer | 17,06k | 0,00 | Derivative Exercise and Retained Stock | - | 40,39k | 73,11% |
| 2026-01-05 | Dr. Paul A. MooreChief Scientific Officer | -20,11k | 504,70k | Derivative Exercise and Sale | 25,10 | 40,39k | - |
| 2025-12-22 | Mr. Kenneth H. GalbraithChairman of the Board, CEO & President | 52,47k | 0,00 | Derivative Exercise and Retained Stock | - | 133,28k | 64,94% |
| 2025-12-22 | Mr. Kenneth H. GalbraithChairman of the Board, CEO & President | -47,53k | 1,28M | Derivative Exercise and Sale | 27,02 | 133,28k | - |
Assistenza: support@advfn.it
Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni
Registrati con e-mail
Hai già un account? Accedi
Non hai un account? Registrati
Registrandomi, confermo di aver letto, capito, e accetto i termini e condizioni ADVFN e che sono un investitore privato.
Caratteristiche principali
Premium
